233 related articles for article (PubMed ID: 21738572)
1. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
Khan JA; Kudgus RA; Szabolcs A; Dutta S; Wang E; Cao S; Curran GL; Shah V; Curley S; Mukhopadhyay D; Robertson JD; Bhattacharya R; Mukherjee P
PLoS One; 2011; 6(6):e20347. PubMed ID: 21738572
[TBL] [Abstract][Full Text] [Related]
2. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.
Elechalawar CK; Hossen MN; Shankarappa P; Peer CJ; Figg WD; Robertson JD; Bhattacharya R; Mukherjee P
Int J Nanomedicine; 2020; 15():991-1003. PubMed ID: 32103952
[TBL] [Abstract][Full Text] [Related]
3. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.
Bhattacharyya S; Bhattacharya R; Curley S; McNiven MA; Mukherjee P
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14541-6. PubMed ID: 20679244
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Curley SA; Cherukuri P; Briggs K; Patra CR; Upton M; Dolson E; Mukherjee P
J Exp Ther Oncol; 2008; 7(4):313-26. PubMed ID: 19227011
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
Ashton JR; Gottlin EB; Patz EF; West JL; Badea CT
PLoS One; 2018; 13(11):e0206950. PubMed ID: 30408128
[TBL] [Abstract][Full Text] [Related]
7. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
[TBL] [Abstract][Full Text] [Related]
8. Switching the targeting pathways of a therapeutic antibody by nanodesign.
Bhattacharyya S; Singh RD; Pagano R; Robertson JD; Bhattacharya R; Mukherjee P
Angew Chem Int Ed Engl; 2012 Feb; 51(7):1563-7. PubMed ID: 22135077
[No Abstract] [Full Text] [Related]
9. Lack of in vivo antibody dependent cellular cytotoxicity with antibody containing gold nanoparticles.
Ahmed M; Pan DW; Davis ME
Bioconjug Chem; 2015 May; 26(5):812-6. PubMed ID: 25879583
[TBL] [Abstract][Full Text] [Related]
10. Folate-Gold-Bilirubin Nanoconjugate Induces Apoptotic Death in Multidrug-Resistant Oral Carcinoma Cells.
Rathinaraj P; Muthusamy G; Prasad NR; Gunaseelan S; Kim B; Zhu S
Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):285-296. PubMed ID: 31858458
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents.
Fernandes AR; Jesus J; Martins P; Figueiredo S; Rosa D; Martins LM; Corvo ML; Carvalheiro MC; Costa PM; Baptista PV
J Control Release; 2017 Jan; 245():52-61. PubMed ID: 27871990
[TBL] [Abstract][Full Text] [Related]
12. Use of Biocompatible Sorafenib-gold Nanoconjugates for Reversal of Drug Resistance in Human Hepatoblatoma Cells.
Vishwakarma SK; Sharmila P; Bardia A; Chandrakala L; Raju N; Sravani G; Sastry BVS; Habeeb MA; Khan AA; Dhayal M
Sci Rep; 2017 Aug; 7(1):8539. PubMed ID: 28819176
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles.
Glazer ES; Zhu C; Massey KL; Thompson CS; Kaluarachchi WD; Hamir AN; Curley SA
Clin Cancer Res; 2010 Dec; 16(23):5712-21. PubMed ID: 21138869
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.
Qian Y; Qiu M; Wu Q; Tian Y; Zhang Y; Gu N; Li S; Xu L; Yin R
Sci Rep; 2014 Dec; 4():7490. PubMed ID: 25502402
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.
Kudgus RA; Szabolcs A; Khan JA; Walden CA; Reid JM; Robertson JD; Bhattacharya R; Mukherjee P
PLoS One; 2013; 8(3):e57522. PubMed ID: 23483913
[TBL] [Abstract][Full Text] [Related]
16. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype.
Hotz B; Keilholz U; Fusi A; Buhr HJ; Hotz HG
Gastric Cancer; 2012 Jul; 15(3):252-64. PubMed ID: 22011788
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Characterization and Anti-Cancer Therapeutic Potential of Withanolide-A with 20nm sAuNPs Conjugates Against SKBR3 Breast Cancer Cell Line.
Tabassam Q; Mehmood T; Raza AR; Ullah A; Saeed F; Anjum FM
Int J Nanomedicine; 2020; 15():6649-6658. PubMed ID: 32982224
[TBL] [Abstract][Full Text] [Related]
19. Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model.
Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin WJ; Chen FD; Lin MH; Wang HE
Nanotechnology; 2014 Jul; 25(29):295102. PubMed ID: 24990295
[TBL] [Abstract][Full Text] [Related]
20. Targeted Delivery of Cisplatin by Gold Nanoparticles: The Influence of Nanocarrier Surface Modification Type on the Efficiency of Drug Binding Examined by CE-ICP-MS/MS.
Wróblewska AM; Milewska A; Drozd M; Matczuk M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
